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Background: Type 1 and type 2 diabetes are characterized by loss of β-cells; therefore, β-cell regeneration has
become one of the primary approaches to diabetes therapy. Resveratrol, a naturally occurring polyphenolic
compound, has been shown to improve glycaemic control in diabetic patients, but its action on pancreatic α-cells
is not well understood.
Findings: Using mouse α-cells (αTC9), we showed that resveratrol induces expression of pancreatic β-cell genes
such as Pdx1 and Ins2 in a SirT1-dependent manner. The mRNA and protein levels of insulin were further increased
by histone deacetylase (HDAC) inhibition.
Conclusion: In summary, we provide new mechanistic insight into the anti-diabetic action of resveratrol through its
ability to express β-cell genes in α-cells.Findings
Resveratrol has been shown to improve glycaemic con-
trol in humans [1]. Animal studies have shown similar
beneficial effects of resveratrol [2] by increasing insulin
secretion or enhancing sensitivity to insulin in periph-
eral organs via activation of SirT1 [3]. Recently, several
reports described the ability of pancreatic α-cells to de-
differentiate into insulin-producing cells after β-cell loss
[4-6]. These findings raise the possibility for new dia-
betic therapies that exploit α-cell plasticity. In this
study, we show that resveratrol can induce expression
of several β-cell genes and insulin expression in pancre-
atic α-cells. Our results shed light on resveratrol action
in α-cells and expand our understanding of its anti-
diabetic effects.
Resveratrol induces re-expression of insulin and other
pancreatic β-cell genes in a SirT1-dependent manner
αTC9 is a subclone selected for high glucagon expression
and virtually no insulin expression [7]. Surprisingly, res-
veratrol significantly increased the expression of mouse
Ins2 mRNA in a SirT1-dependent mechanism in these* Correspondence: paul.yen@duke-nus.edu.sg
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reproduction in any medium, provided the orcells after 24 hr of treatment (Figure 1A, B) while gluca-
gon mRNA was not significantly altered (Figure 1A). Next,
we examined the expression of other β-cell markers
(Ngn3, NeuroD1, Nkx6.1, FoxO1 and Pdx1) that regulate
pancreatic β-cell differentiation and insulin gene tran-
scription in α-cells. Interestingly, resveratrol increased
expression of key β-cell transcription factors such as Pdx1
as well as Ngn3, NeuroD1, Nkx6.1 and FoxO1 (Figure 1C).
Similar to its effect on insulin expression, resveratrol’s
induction of Pdx1 was found to be SirT1-dependent
whereas Ngn3 expression did not depend upon SirT1
(Figure 1D).Re-expression of insulin gene by resveratrol in α-cells is
enhanced by HDAC inhibition
Earlier studies of Pdx1 showed that it induced histone
acetylation at the insulin promoter [8]. Therefore we per-
formed ChIP-qPCR for acetylated histone H3 and H4,
spanning the enhancer binding site of Pdx1 in the insulin
promoter region. Our results showed a significant increase
in H3 and H4 acetylation after resveratrol treatment,
which was further enhanced by the co-administration of a
HDAC inhibitor, Trichostatin A (TSA) (Figure 2A). This
increase in promoter acetylation also correlated with. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Resveratrol increase insulin mRNA levels in α-cells via SirT1. (A) qPCR analysis of Ins2 and Gcg mRNA levels after resveratrol
treatment (25 μM / 24 hr) with or without SirT1 KD in α-cells. (B) Immunoblot showing efficiency of SirT1 knockdown in α-cells. (C, D) qPCR
analysis of endocrine progenitor and β-cell specific markers after resveratrol treatment (25 μM / 24 hr). Bars represent the mean of the respective
individual ratios ± SEM (n = 3). (D) qPCR analysis of Pdx1 and Ngn3 mRNA levels after resveratrol treatment (25 μM / 24 hr) with or without SirT1
KD in α-cells. The asterisk indicates P < 0.05.
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used rat INS-1cells (pancreatic β-cell line) to see the effect
of resveratrol and TSA on insulin gene. Interestingly, we
observed little or no induction of insulin gene expression
by resveratrol and/or TSA in a β-cell line (Figure 2C). This
finding suggests that resveratrol and HDAC inhibitors
may be more effective in inducing insulin in heterologous
cells where it is normally repressed. To validate increased
insulin protein expression, RIA was used to quantify the
insulin content in α-cells. Although no significant in-
crease in intracellular insulin protein was detectable in
resveratrol- or TSA-treated cells (data not shown), there
was a significant increase in insulin protein after resver-
atrol and TSA co-treatment (Figure 2C).
Resveratrol has emerged as a promising anti-diabetic
agent that exhibits significant ability to lower serum glucose
in diabetic patients [2]. Recent experiments in genetically-
manipulated mice have established that α-cells can directly
trans-differentiate into β-cells under certain conditions
such as β-cell loss in lineage-traced mice [4]. While the in-
duction of β-cell genes such as Pdx1 can lead to insulin
expression in α-cells [8,9], cell transformation leading to
expression of β-cell genes is another potential strategy toincrease insulin production [5]. In this regard, several new
drugs are being developed that modulate α-cell plasticity
[10]. Our observation that resveratrol was able to induce
insulin synthesis in α-cells is germane since it currently is
undergoing clinical trials for treatment of type 2 diabetes.
The insulin-inducing effect on α-cells by resveratrol was
SirT1-dependent. Furthermore, the induction of Pdx1 by
resveratrol and the accompanying epigenetic changes on
the insulin promoter suggests that it may have a broader
reprogramming action than mere stabilization of low
abundance insulin mRNA in these cells. In this connec-
tion, using an HDAC inhibitor in combination with res-
veratrol further enhanced insulin induction at both the
mRNA and protein levels. In summary, our findings dem-
onstrating the effects of resveratrol on α-cell plasticity
provide a new understanding of its anti-diabetic actions
and point towards novel treatment strategies for diabetes.
Materials and methods
Cell culture
αTC9 cells, a mouse pancreatic α-cell line [7], were grown
in DMEM containing 1 g/L glucose, supplemented with
10% FBS, 50 U/mL penicillin and 50 U/mL streptomycin.
Figure 2 Resveratrol induced insulin levels are enhanced further by HDAC inhibition. (A) ChIP-qPCR analysis showing H3/H4 acetylation
at Ins2 promoter after resveratrol alone (25 μM / 24 hr) or TSA (50 nM) co-treatment in αTC9. (B) qPCR analysis of Ins2 mRNA after resveratrol
alone (25 μM / 24 hr) or TSA (50 nM / 24 hr) co-treatment in αTC9. (C) qPCR analysis of Ins2 mRNA after resveratrol alone (25 μM / 24 hr) or
TSA (50 nM / 24 hr) co-treatment in INS-1 cells. (D) RIA measurement of intracellular insulin protein after resveratrol (25 μM / 24 hr) and TSA
(50 nM / 24 hr) co-treatment in α-cells. Bars represent the mean of the respective individual ratios ± SEM (n = 3). The asterisk indicates P < 0.05.
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for 24 hr. SirT1 knockdown was performed using Silencer
Select duplex oligo-ribonucleotides targeting mouse SirT1
and a non-targeting control siRNA (Life Technologies,
USA). In knockdown studies, resveratrol was added for
24 hr after 2 days of knockdown. Rat INS-1 cells were cul-
tured using standard protocol.RNA isolation and real-time PCR (qPCR)
Total RNA was isolated using Invitrap Spin Cell RNA
Mini Kit (Stratec Molecular, Germany) and qPCR was
performed using the QuantiFast SYBR Green PCR Kit
(QIAGEN, USA) according to the manufacturer’s instruc-
tions. Samples were normalised to actin. Fold changes
were calculated using 2-ddCt.
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Cells were lysed using Celytic M mammalian lysis buffer
(Sigma-Aldrich, USA) and immunobloting was performed
according to manufacturer’s instructions (Bio-Rad, USA).
Densitometry analysis was performed using Image J soft-
ware (NIH, USA).
Chromatin immunoprecipitation (ChIP)–qPCR analysis
ChIP assays using control rabbit IgG (Santa Cruz,
USA), anti-acetylated histone H3 (Abcam, USA) and
anti-acetylated histone H4 (Merck-Millipore, USA) were
performed using Magna ChIP™ G - Chromatin Immuno-
precipitation Kit (Merck-Millipore, USA) according to
manufacturer’s instructions. 2 μL of immunoprecipitated
DNA or 1% input DNA was used with QuantiFast SYBR
Green PCR Kit (QIAGEN, USA) for 40 cycles of qPCR
using Rotor-Gene® Q (QIAGEN, USA). Primers used amp-
lify the Pdx1 binding region (−126 to −296) on the insulin
promoter.
Insulin measurement by radioimmunoassay (RIA)
Cells were lysed and extracted by acid-ethanol and insulin
content was assayed by RIA (Linco Research, USA).
Statistical analysis
Compound treatments were performed in triplicate and
repeated at least three times independently using matched
controls. The data were pooled and results were expressed
as mean ± SEM. The statistical significance of differences
(P < 0.05) was assessed by two-tailed student’s t-test.
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